By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

NKT Therapeutics Inc. 

233 Needham Street

Newton  Massachusetts  02464  U.S.A.
Phone: 617-454-1008 Fax: 617-454-1009


SEARCH JOBS


Industry
Biotechnology






Company News
NKT Therapeutics Inc. Presents Data On Its Therapeutic Program Targeting Sickle Cell Disease At The American Society of Hematology 12/8/2014 9:22:25 AM
NKT Therapeutics Inc. To Present Data On Its Therapeutic Program Targeting Sickle Cell Disease At The American Society of Hematology 11/6/2014 9:34:25 AM
FDA Grants Fast Track Designation To NKT Therapeutics Inc.' NKTT120 For The Treatment Of Sickle Cell Disease 10/2/2014 9:16:34 AM
NKT Therapeutics Inc. Reports First Clinical Results With Anti-iNKT Antibody In Patients With Sickle Cell Disease 12/10/2013 10:42:59 AM
NKT Therapeutics Inc. Presents Data on Potential Antibody Treatment for Sickle Cell Disease 12/6/2012 9:48:21 AM
DSM Pharmaceutical Products and NKT Therapeutics Inc. Sign Contract for Lead Product Development and Manufacture 2/8/2011 10:21:39 AM
DSM Biologics and NKT Therapeutics Inc. Sign Contract for Lead Product Development and Manufacture 2/8/2011 8:05:42 AM
NKT Therapeutics Inc. Announces Hiring of Barbara Finck, M.D. as Chief Medical Officer 10/5/2010 10:36:45 AM
BioWa and NKT Therapeutics Inc. Announce Licensing of BioWa's POTELLIGENT(R) Technology For Use in Antibody Research and Development 10/21/2009 9:34:57 AM
Selexis SA and NKT Therapeutics Inc. Enter Into Research Services Agreement 9/1/2009 11:05:09 AM
12
//-->